Krystal Biotech Inc (KRYS)

Inventory turnover

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Cost of revenue (ttm)	US$ in thousands	97,854	96,536	95,405	91,643	83,602	75,785	65,603	55,240	47,176	38,941	31,446	26,454	19,970	13,729	12,173	9,050	7,409	6,489	5,716	5,183
Inventory	US$ in thousands	11,037	6,985	5,278	1,100	—	0	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Inventory turnover		8.87	13.82	18.08	83.31	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

March 31, 2024 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $97,854K ÷ $11,037K
= 8.87

The inventory turnover ratio for Krystal Biotech Inc has displayed fluctuating trends over the past few quarters. The ratio was 8.87 as of March 31, 2024, indicating that the company turned over its inventory approximately 8.87 times during the year.

Compared to the inventory turnover ratio of 13.82 on December 31, 2023, and 18.08 on September 30, 2023, the latest ratio suggests a decrease in the efficiency of inventory management. However, it is still higher than the ratios reported in previous quarters, including a notably high ratio of 83.31 on June 30, 2023.

It is important to note that the absence of data for March 31, 2023, indicates a potential gap in the company's reporting, which may affect the trend analysis. A sustained high inventory turnover ratio generally suggests effective inventory management and liquidity benefits, while a significant decrease may require further investigation into the company's inventory control and sales performance.